353 related articles for article (PubMed ID: 16546214)
1. Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation.
Mason BJ; Goodman AM; Chabac S; Lehert P
J Psychiatr Res; 2006 Aug; 40(5):383-93. PubMed ID: 16546214
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of acamprosate for alcohol dependence in a family medicine setting in the United States: a randomized, double-blind, placebo-controlled study.
Berger L; Fisher M; Brondino M; Bohn M; Gwyther R; Longo L; Beier N; Ford A; Greco J; Garbutt JC
Alcohol Clin Exp Res; 2013 Apr; 37(4):668-74. PubMed ID: 23134193
[TBL] [Abstract][Full Text] [Related]
3. Acamprosate treatment in a long-term community-based alcohol rehabilitation programme.
Poldrugo F
Addiction; 1997 Nov; 92(11):1537-46. PubMed ID: 9519495
[TBL] [Abstract][Full Text] [Related]
4. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.
Staner L; Boeijinga P; Danel T; Gendre I; Muzet M; Landron F; Luthringer R
Alcohol Clin Exp Res; 2006 Sep; 30(9):1492-9. PubMed ID: 16930211
[TBL] [Abstract][Full Text] [Related]
5. Treatment of alcohol-dependent outpatients with acamprosate: a clinical review.
Mason BJ
J Clin Psychiatry; 2001; 62 Suppl 20():42-8. PubMed ID: 11584875
[TBL] [Abstract][Full Text] [Related]
6. Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.
Namkoong K; Lee BO; Lee PG; Choi MJ; Lee E
Alcohol Alcohol; 2003; 38(2):135-41. PubMed ID: 12634260
[TBL] [Abstract][Full Text] [Related]
7. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
[TBL] [Abstract][Full Text] [Related]
8. Effect of early and late compliance on the effectiveness of acamprosate in the treatment of alcohol dependence.
Koeter MW; van den Brink W; Lehert P
J Subst Abuse Treat; 2010 Oct; 39(3):218-26. PubMed ID: 20627222
[TBL] [Abstract][Full Text] [Related]
9. Alcohol-use disorders and depression: results from individual patient data meta-analysis of the acamprosate-controlled studies.
Lejoyeux M; Lehert P
Alcohol Alcohol; 2011; 46(1):61-7. PubMed ID: 21118900
[TBL] [Abstract][Full Text] [Related]
10. Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study.
Mann K; Lemenager T; Hoffmann S; Reinhard I; Hermann D; Batra A; Berner M; Wodarz N; Heinz A; Smolka MN; Zimmermann US; Wellek S; Kiefer F; Anton RF;
Addict Biol; 2013 Nov; 18(6):937-46. PubMed ID: 23231446
[TBL] [Abstract][Full Text] [Related]
11. Acamprosate for the treatment of alcohol dependence.
Boothby LA; Doering PL
Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
[TBL] [Abstract][Full Text] [Related]
12. Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain.
Gual A; Lehert P
Alcohol Alcohol; 2001; 36(5):413-8. PubMed ID: 11524307
[TBL] [Abstract][Full Text] [Related]
13. Urinary ethyl glucuronide and ethyl sulfate testing for recent drinking in alcohol-dependent outpatients treated with acamprosate or placebo.
Dahl H; Hammarberg A; Franck J; Helander A
Alcohol Alcohol; 2011; 46(5):553-7. PubMed ID: 21616946
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic effects of acamprosate on markers of cerebral function in alcohol-dependent subjects administered as pretreatment and during alcohol abstinence.
Boeijinga PH; Parot P; Soufflet L; Landron F; Danel T; Gendre I; Muzet M; Demazières A; Luthringer R
Neuropsychobiology; 2004; 50(1):71-7. PubMed ID: 15179024
[TBL] [Abstract][Full Text] [Related]
15. Acamprosate in the treatment of alcohol dependence.
Mason BJ
Expert Opin Pharmacother; 2005 Oct; 6(12):2103-15. PubMed ID: 16197362
[TBL] [Abstract][Full Text] [Related]
16. Acamprosate efficacy in alcohol-dependent patients: summary of results from three pivotal trials.
Kranzler HR; Gage A
Am J Addict; 2008; 17(1):70-6. PubMed ID: 18214726
[TBL] [Abstract][Full Text] [Related]
17. Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol.
Paille FM; Guelfi JD; Perkins AC; Royer RJ; Steru L; Parot P
Alcohol Alcohol; 1995 Mar; 30(2):239-47. PubMed ID: 7662044
[TBL] [Abstract][Full Text] [Related]
18. The effects of combined acamprosate and integrative behaviour therapy in the outpatient treatment of alcohol dependence: a randomized controlled trial.
Wölwer W; Frommann N; Jänner M; Franke PE; Scherbaum N; Lieb B; Falkai P; Wobrock T; Kuhlmann T; Radermacher M; Maier W; Schütz C; Ohmann C; Burtscheidt W; Gaebel W
Drug Alcohol Depend; 2011 Nov; 118(2-3):417-22. PubMed ID: 21621929
[TBL] [Abstract][Full Text] [Related]
19. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
[TBL] [Abstract][Full Text] [Related]
20. Increasing leptin precedes craving and relapse during pharmacological abstinence maintenance treatment of alcoholism.
Kiefer F; Jahn H; Otte C; Demiralay C; Wolf K; Wiedemann K
J Psychiatr Res; 2005 Sep; 39(5):545-51. PubMed ID: 15992564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
